<!DOCTYPE html>
<html>
<head>
    <title>China&#x2019;s Sinopharm vac&#xAD;cine found to have 86% ef&#xAD;fi&#xAD;cacy - PressReader</title>
    <meta name="description" content="">
    <meta content="magazines, newspapers, digital news, reading, news, breaking news, newspaper online" name="keywords">
    <meta name="Robots" content="NOARCHIVE,NOODP">
    <meta charset="UTF-8">
    <meta http-equiv="Content-type" content="text/html; charset=utf-8" />
    <meta name="viewport" content="width=device-width, initial-scale=1" />
    
    <link rel="canonical" href="/singapore/the-straits-times/20201210/281694027360439" />


    <style>
        li {
            margin: 1em 0;
        }
        img {
            max-width: 100%;
        }
        p, h1, h2, h3 {
            max-width: 100%;
        }
    </style>
</head>
<body>
    <div>
        

<article>
    <h1>China&#x2019;s Sinopharm vac&#xAD;cine found to have 86% ef&#xAD;fi&#xAD;cacy</h1>
    <h2></h2>
    <section>
        <a href="/singapore/the-straits-times/textview" title="The Straits Times">The Straits Times</a>
        - <a href="/singapore/the-straits-times/20201210/textview" title="The Straits Times - 2020-12-10"><time>2020-12-10</time></a>
        - <span>WORLD</span>
        - <span role="byline"></span>
    </section>

    <p>DUBAI • An ex­per­i­men­tal coro­n­avirus vac­cine de­vel­oped by China Na­tional Phar­ma­ceu­ti­cal Group (Sinopharm) has 86 per cent ef­fi­cacy, the health min­istry of the United Arab Emi­rates said yes­ter­day, cit­ing an in­terim anal­y­sis of late-stage clin­i­cal tri­als.</p>
    <p>While the pos­i­tive data comes soon af­ter last month’s up­beat re­sults from Western ri­vals, nei­ther the UAE nor Sinopharm has re­leased de­tailed data from the piv­otal study.</p>
    <p>In July, the Gulf Arab state started phase three clin­i­cal tri­als of the vac­cine, de­vel­oped by Bei­jing In­sti­tute of Bi­o­log­i­cal Prod­ucts, a unit of Sinopharm’s China Na­tional Biotec Group (CNBG).</p>
    <p>In Septem­ber, it au­tho­rised emer­gency use of the vac­cine for cer­tain groups, the first such in­ter­na­tional clear­ance for a vac­cine de­vel­oped in China.</p>
    <p>The anal­y­sis also shows “99 per cent se­ro­con­ver­sion rate of neu­tral­is­ing an­ti­body and 100 per cent ef­fec­tive­ness in pre­vent­ing mod­er­ate and se­vere cases of the dis­ease”, the min­istry said.</p>
    <p>“The anal­y­sis shows no se­ri­ous safety con­cerns,” it said, adding that it had of­fi­cially reg­is­tered the vac­cine and that 31,000 vol­un­teers across 125 na­tion­al­i­ties par­tic­i­pated in the UAE trial. It did not say what side ef­fects it iden­ti­fied or how many vol­un­teers fell ill.</p>
    <p>The vac­cine, which uses an in­ac­ti­vated virus un­able to repli­cate hu­man cells to trig­ger im­mune re­sponses, re­quires two doses.</p>
    <p>The UAE trial is a part­ner­ship be­tween CNBG, Abu Dhabi-based ar­ti­fi­cial in­tel­li­gence com­pany Group 42 (G42) and the Abu Dhabi Depart­ment of Health.</p>
    <p>Sinopharm and G42 have also ex­panded the trial to Egypt, Jor­dan and Bahrain.</p>
    <p>The vac­cine is among the three most ad­vanced can­di­dates from China in terms of de­vel­op­ment and has been used to vac­ci­nate around one mil­lion peo­ple in the coun­try un­der its emer­gency use pro­gramme.</p>


</article>

<section>
    <h3><a href="/catalog/language/english">Newspapers in English</a></h3>
    <h3><a href="/catalog/country/singapore">Newspapers from Singapore</a></h3>
</section>

    </div>
    
    <p><a href="http://www.pressreader.com">© PressReader. All rights reserved.</a></p>

        <script>
            (function (i, s, o, g, r, a, m) {
                i['GoogleAnalyticsObject'] = r; i[r] = i[r] || function () {
                    (i[r].q = i[r].q || []).push(arguments);
                }, i[r].l = 1 * new Date();
                a = s.createElement(o), m = s.getElementsByTagName(o)[0]; a.async = 1; a.src = g;
                m.parentNode.insertBefore(a, m);
            })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
        </script>
        <script>
            ga('create', 'UA-44408245-1');
            ga('send', 'pageView');
        </script>
</body>
</html>
